Bio-Rad develops, manufactures, and markets a broad range of products and solutions for the life science research and clinical diagnostics markets. The Company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market.
TypePublic
HQHercules, US
Founded1952
Size (employees)8,150 (est)-1%
Websitebio-rad.com
Bio-Rad was founded in 1952 and is headquartered in Hercules, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Bio-Rad

Norman Schwartz

Norman Schwartz

Chairman of the Board, President and Chief Executive Officer
Giovanni Magni

Giovanni Magni

EVP, Chief Strategy Officer
John Goetz

John Goetz

EVP, Chief Operating Officer
Michael Crowley

Michael Crowley

EVP, Global Commercial Operations
John Hertia

John Hertia

EVP, President, Clinical Diagnostics Group
Tim Ernst

Tim Ernst

EVP, General Counsel & Secretary
Show more

Bio-Rad Office Locations

Bio-Rad has offices in Caracas, Montevideo, Alcobendas, Randburg and in 54 other locations
Hercules, US (HQ)
1000 Alfred Nobel Dr
Hercules, US
4000 Alfred Nobel Dr
Hercules, US
2000 Alfred Nobel Drive
Hialeah, US
Suite D-7 6095 NW 167th St
Villa Ortúzar, AR
964 Estomba
Gladesville, AU
Level 5 446 Victoria Rd
Show all (68)
Report incorrect company information

Bio-Rad Financials and Metrics

Bio-Rad Revenue

Bio-Rad's revenue was reported to be $2.16 b in FY, 2017 which is a 4.4% increase from the previous period.
USD

Revenue (Q2, 2018)

1.1b

Gross profit (Q2, 2018)

603.9m

Gross profit margin (Q2, 2018), %

53.6%

Market capitalization (15-Oct-2018)

8.3b

Closing stock price (15-Oct-2018)

277.8

Cash (30-Jun-2018)

403.0m
Bio-Rad's current market capitalization is $8.3 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

2.1b2.2b2.0b2.1b2.2b

Revenue growth, %

2%(7%)2%4%

Cost of goods sold

897.8m930.1m972.8m

Gross profit

1.1b1.1b1.2b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

505.1m509.3m536.8m530.6m472.8m506.1m470.0m471.2m516.8m508.7m500.1m504.7m551.5m1.1b

Cost of goods sold

220.9m234.1m239.6m242.1m202.7m226.5m206.5m207.2m236.5m229.3m230.1m231.4m249.3m523.6m

Gross profit

284.2m275.3m297.2m288.6m270.1m279.6m263.5m264.0m280.2m279.5m270.0m273.3m302.2m603.9m

Gross profit Margin, %

56%54%55%54%57%55%56%56%54%55%54%54%55%54%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

331.6m413.3m457.5m456.3m383.8m

Accounts Receivable

372.3m464.8m

Prepaid Expenses

91.0m146.1m

Inventories

525.0m594.8m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

291.8m364.5m384.7m424.6m425.7m450.1m507.3m403.6m418.7m417.9m291.7m321.6m407.3m403.0m

Accounts Receivable

383.5m383.9m378.9m354.4m342.2m354.2m341.5m381.1m366.3m367.7m373.4m392.8m430.4m404.1m

Inventories

523.5m513.9m520.6m516.0m478.4m501.0m512.7m533.3m541.5m556.4m559.8m580.6m612.2m591.4m

Current Assets

1.7b1.8b1.8b1.8b1.7b1.7b1.8b1.8b1.8b1.9b1.7b1.8b2.0b2.0b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

77.8m88.8m113.1m

Inventories

Accounts Payable

Cash From Operating Activities

175.5m273.3m186.2m216.4m103.9m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

31.6m11.5m17.8m28.4m17.4m12.3m30.3m48.7m12.4m

Accounts Payable

125.5m126.6m

Cash From Operating Activities

40.3m118.2m

Cash From Investing Activities

(18.8m)(102.7m)
USDY, 2018

Financial Leverage

1.4 x
Show all financial metrics

Bio-Rad Revenue Breakdown

Embed Graph

Bio-Rad revenue breakdown by business segment: 36.3% from Life Science, 63.0% from Clinical Diagnostics and 0.7% from Other

Bio-Rad revenue breakdown by geographic segment: 6.5% from Other (primarily Canada and Latin America), 37.0% from United States, 21.4% from Pacific Rim and 35.1% from Europe

Report incorrect company information

Bio-Rad Online and Social Media Presence

Embed Graph
Report incorrect company information

Bio-Rad Company Life and Culture

Report incorrect company information